152 related articles for article (PubMed ID: 37979448)
1. Glyburide-treated human monocyte-derived dendritic cells loaded with insulin represent tolerogenic features with anti-inflammatory responses and modulate autologous T cell responses in vitro.
Alipour S; Kazemi T; Sadeghi MR; Heris JA; Masoumi J; Naseri B; Baghbani E; Sohrabi S; Baradaran B
Int Immunopharmacol; 2024 Jan; 126():111230. PubMed ID: 37979448
[TBL] [Abstract][Full Text] [Related]
2. Tolerogenic Dendritic Cells from Poorly Compensated Type 1 Diabetes Patients Have Decreased Ability To Induce Stable Antigen-Specific T Cell Hyporesponsiveness and Generation of Suppressive Regulatory T Cells.
Dáňová K; Grohová A; Strnadová P; Funda DP; Šumník Z; Lebl J; Cinek O; Průhová Š; Koloušková S; Obermannová B; Petruželková L; Šedivá A; Fundová P; Buschard K; Špíšek R; Palová-Jelínková L
J Immunol; 2017 Jan; 198(2):729-740. PubMed ID: 27927966
[TBL] [Abstract][Full Text] [Related]
3. Autologous tolerogenic dendritic cells derived from monocytes of systemic lupus erythematosus patients and healthy donors show a stable and immunosuppressive phenotype.
Obreque J; Vega F; Torres A; Cuitino L; Mackern-Oberti JP; Viviani P; Kalergis A; Llanos C
Immunology; 2017 Dec; 152(4):648-659. PubMed ID: 28763099
[TBL] [Abstract][Full Text] [Related]
4. Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (tolDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NOD Mice.
Funda DP; Goliáš J; Hudcovic T; Kozáková H; Špíšek R; Palová-Jelínková L
Front Immunol; 2018; 9():290. PubMed ID: 29503651
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory Dual-Sized Microparticle System Conditions Human Antigen Presenting Cells Into a Tolerogenic Phenotype
Brusko MA; Stewart JM; Posgai AL; Wasserfall CH; Atkinson MA; Brusko TM; Keselowsky BG
Front Immunol; 2020; 11():574447. PubMed ID: 33193362
[TBL] [Abstract][Full Text] [Related]
6. Tolerogenic dendritic cells generated
Dao Nyesiga G; Pool L; Englezou PC; Hylander T; Ohlsson L; Appelgren D; Sundstedt A; Tillerkvist K; Romedahl HR; Wigren M
Front Immunol; 2023; 14():1045183. PubMed ID: 37901231
[TBL] [Abstract][Full Text] [Related]
7. 1,25-dihydroxyvitamin D3 induces stable and reproducible therapeutic tolerogenic dendritic cells with specific epigenetic modifications.
van Megen KM; Chen Z; Joosten AM; Laban S; Zwaginga JJ; Natarajan R; Nikolic T; Roep BO
Cytotherapy; 2021 Mar; 23(3):242-255. PubMed ID: 33461863
[TBL] [Abstract][Full Text] [Related]
8. Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis.
Harry RA; Anderson AE; Isaacs JD; Hilkens CM
Ann Rheum Dis; 2010 Nov; 69(11):2042-50. PubMed ID: 20551157
[TBL] [Abstract][Full Text] [Related]
9. Multidimensional analyses of proinsulin peptide-specific regulatory T cells induced by tolerogenic dendritic cells.
Suwandi JS; Laban S; Vass K; Joosten A; van Unen V; Lelieveldt BPF; Höllt T; Zwaginga JJ; Nikolic T; Roep BO
J Autoimmun; 2020 Feb; 107():102361. PubMed ID: 31776056
[TBL] [Abstract][Full Text] [Related]
10. Induction of Interleukin-10 Producing Dendritic Cells As a Tool to Suppress Allergen-Specific T Helper 2 Responses.
Schülke S
Front Immunol; 2018; 9():455. PubMed ID: 29616018
[TBL] [Abstract][Full Text] [Related]
11. Genetic and Epigenetic Regulation of the Innate Immune Response to Gout.
de Lima JD; de Paula AGP; Yuasa BS; de Souza Smanioto CC; da Cruz Silva MC; Dos Santos PI; Prado KB; Winter Boldt AB; Braga TT
Immunol Invest; 2023 Apr; 52(3):364-397. PubMed ID: 36745138
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylserine-Liposomes Promote Tolerogenic Features on Dendritic Cells in Human Type 1 Diabetes by Apoptotic Mimicry.
Rodriguez-Fernandez S; Pujol-Autonell I; Brianso F; Perna-Barrull D; Cano-Sarabia M; Garcia-Jimeno S; Villalba A; Sanchez A; Aguilera E; Vazquez F; Verdaguer J; Maspoch D; Vives-Pi M
Front Immunol; 2018; 9():253. PubMed ID: 29491866
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of NEAT1 induces tolerogenic phenotype in dendritic cells by inhibiting activation of NLRP3 inflammasome.
Zhang M; Zheng Y; Sun Y; Li S; Chen L; Jin X; Hou X; Liu X; Chen Q; Li J; Liu M; Zheng X; Zhang Y; Wu J; Yu B
Theranostics; 2019; 9(12):3425-3442. PubMed ID: 31281488
[No Abstract] [Full Text] [Related]
14. A short protocol using dexamethasone and monophosphoryl lipid A generates tolerogenic dendritic cells that display a potent migratory capacity to lymphoid chemokines.
García-González P; Morales R; Hoyos L; Maggi J; Campos J; Pesce B; Gárate D; Larrondo M; González R; Soto L; Ramos V; Tobar P; Molina MC; Pino-Lagos K; Catalán D; Aguillón JC
J Transl Med; 2013 May; 11():128. PubMed ID: 23706017
[TBL] [Abstract][Full Text] [Related]
15. Differential transcriptome of tolerogenic versus inflammatory dendritic cells points to modulated T1D genetic risk and enriched immune regulation.
Nikolic T; Woittiez NJC; van der Slik A; Laban S; Joosten A; Gysemans C; Mathieu C; Zwaginga JJ; Koeleman B; Roep BO
Genes Immun; 2017 Sep; 18(3):176-183. PubMed ID: 28794505
[TBL] [Abstract][Full Text] [Related]
16. Unmasking the NLRP3 inflammasome in dendritic cells as a potential therapeutic target for autoimmunity, cancer, and infectious conditions.
Alipour S; Mardi A; Shajari N; Kazemi T; Sadeghi MR; Ahmadian Heris J; Masoumi J; Baradaran B
Life Sci; 2024 Jul; 348():122686. PubMed ID: 38710282
[TBL] [Abstract][Full Text] [Related]
17. Tolerogenic dendritic cells for reprogramming of lymphocyte responses in autoimmune diseases.
García-González P; Ubilla-Olguín G; Catalán D; Schinnerling K; Aguillón JC
Autoimmun Rev; 2016 Nov; 15(11):1071-1080. PubMed ID: 27485011
[TBL] [Abstract][Full Text] [Related]
18. Modulation of dendritic cell by pathogen antigens: Where do we stand?
Peron G; de Lima Thomaz L; Camargo da Rosa L; Thomé R; Cardoso Verinaud LM
Immunol Lett; 2018 Apr; 196():91-102. PubMed ID: 29427742
[TBL] [Abstract][Full Text] [Related]
19. AIRE is not essential for the induction of human tolerogenic dendritic cells.
Crossland KL; Abinun M; Arkwright PD; Cheetham TD; Pearce SH; Hilkens CM; Lilic D
Autoimmunity; 2016 Jun; 49(4):211-8. PubMed ID: 26912174
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells.
Gonzalez-Rey E; Chorny A; Fernandez-Martin A; Ganea D; Delgado M
Blood; 2006 May; 107(9):3632-8. PubMed ID: 16397128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
